Characterization of human and rodent native and recombinant adenosine A2B receptors by radioligand binding studies

Purinergic Signalling

Volumn 2, Issue 3, 2006, Pages 559-571

  Bertarelli, Daniela C G ^a   Diekmann, Martina ^a   Hayallah, Alaa M ^a   Rüsing, Dorothee ^b   Iqbal, Jamshed ^a   Preiss, Birgit ^a   Verspohl, Eugen J ^b   Müller, Christa E ^c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Pharmazeutisches Institut   (Germany)

Author keywords

3H PSB 298; A2B antagonist radioligand; Adenosine A2B receptor; CHO cells; HEK 293 cells; INS 1 cells; NG108 15 cells; Sodium shift assays

Indexed keywords

EID: 33748543969     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-006-9012-4     Document Type: Article

References (40)

1. 2B adenosine receptors. Curr Top Med Chem 3:427-433
2. 2B receptor as a novel therapeutic target in asthma. Br J Pharmacol 145:1009-1015
3. 2B adenosine receptor antagonists. J Pharmacol Exp Ther 308:358-366
4. 2B receptors: A novel therapeutic target in asthma? Trends Pharmacol Sci 19:148-153
5. 2B receptor. J Med Chem 44:170-179
6. 2B adenosine receptors. Drug Des Discov 16:217-226.
7. q in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56:705-713
8. Robeva AS, Woodard R, Jin X et al (1996) Molecular characterization of recombinant human adenosine receptors. Drug Dev Res 39:243-252
9. 2B adenosine receptors. Biochem Pharmacol 61:657-663
10. 2B adenosine receptors. Bioorg Med Chem 14:3607-3610
11. 2B receptors. Biochem Pharmacol 70:1601-1612
12. 2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20. Mol Pharmacol 67:2137-2147
13. 2B receptors. Biochem Pharmacol 68:305-312
14. 2A adenosine receptors. Eur J Pharm Sci 10:259-265
15. 3 adenosine receptors. Bioorg Med Chem Lett 12:501-503
16. 2B-selective adenosine receptor antagonists. J Med Chem 45:1500-1510
17. Müller CE (1991) Synthesis of 3-substituted 6-aminouracils. Tetrahedron Lett 32:6539-6540
18. Klotz KN, Hessling J, Hegler J et al (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stable transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 357:1-9
19. Kaulich M, Qurishi R, Müller CE (2003) Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis. Cell Mol Neurobiol 23:349-364
20. 2b adenosine receptors in NG108-15 cells. Biochem Pharmacol 55:595-603
21. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275
22. Seifert R, Wenzel-Seifert K (2002) Constitutive activity of G protein-coupled receptors: Cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366:381-416
23. de Ligt RA, Kourounakis AP, IJzerman AP (2000) Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br J Pharmacol 130:1-12
24. 2B adenosine receptors of xanthine derivatives substituted at the 1-,3-,7-, and 8-positions. J Med Chem 45:2131-2138
25. Motulsky R, Insel PA (1983) Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding. J Biol Chem 258:3913-3919
26. Conigrave AD, Franks AH (2003) Allosteric activation of plasma membrane receptors - physiological implications and structural origins. Prog Biophys Mol Biol 81:219-240
27. Tsai BS, Lefkowitz RJ (1978) Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled α-adrenergic receptors in rabbit platelets. Mol Pharmacol 14:540-548
28. 1 adenosine receptor: Influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. Mol Pharmacol 50:1635-1642
29. 2A adenosine receptors by amiloride analogues and sodium ions. Biochem Pharmacol 60:669-676
30. Vogel R, Fan GB, Sheves M et al (2001) Salt dependence of the formation and stability state in G protein-coupled receptors: Evidence for the involvement of the Hofmeister effect. Biochemistry 40:483-493
31. 2A receptors in human brain. Neuropharmacology 39:2374-2380
32. 1 adenosine receptor/G protein coupling: Identification of a membrane protein complex. Mol Pharmacol 48:806-817
33. β4. Mol Pharmacol 61:455-462
34. Hamprecht B (1977) Structural, electrophysical, biochemical and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. Int Rev Cytol 49:99-170
35. Ohkubo S, Nakanishi H, Kimura J et al (2000) Effects of AMP derivatives on cyclic AMP levels in NG108-15 cells. Br J Pharmacol 129:1244-1250
36. 1 subtype adenosine receptor on pancreatic insulin-secreting cells. Eur J Pharmacol 36:109-112
37. 2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br J Pharmacol 86:565-569
38. LaNoue KF et al (2002) Control of blood glucose by insulin and adenosine receptor antagonists. In: Abstract no. 226 of the 7th international symposium on adenosine and adenine nucleotides, Gold Coast, Australia
39. Mino RP, Spoerri PE, Caballero S et al (2001) Adenosine receptor antagonists and retinal neovascularization in vivo. Investig Ophthalmol Vis Sci 42:332-334
40. 1 receptor binding and function using 2-amino-3-benzoylthiophenes. Mol Pharmacol 38:939-949